Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2017-04-21 Regulatory Filings
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Regulatory Filings Classification · 98% confidence The document is clearly identified by the header 'RNS Number : 0217D' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' filed by FMR LLC regarding an acquisition/disposal of voting rights that crossed the 10% threshold for Dechra Pharmaceuticals PLC. This type of mandatory disclosure regarding significant changes in share ownership is a specific regulatory filing type. While it relates to share ownership (which could sometimes overlap with MRQ), the format and explicit reference to RNS strongly suggest the general regulatory announcement category, which is RNS, or potentially MRQ if the focus was solely on the major shareholding notification aspect. Given the explicit RNS branding and the nature of the form (TR-1), RNS is the most appropriate general classification for this regulatory notification, although MRQ (Major Shareholding Notification) is also highly relevant. Since RNS is defined as the fallback for miscellaneous regulatory filings, and this is a standard regulatory disclosure format, I will classify it as RNS, as it is a direct regulatory news service announcement.
2017-04-21 English
Additional Listing
Delisting Announcement Classification · 99% confidence The document is very short (2032 characters) and begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's news service. The content explicitly states that an application has been made for the admission of 75,000 ordinary shares to the Official List under a SAYE Scheme. This relates to a change in the company's share capital structure or issuance plan. While it involves shares, it is not a general share issue announcement (SHA) but a specific notification about listing arrangements. Since it is a general regulatory announcement disseminated through RNS that doesn't fit perfectly into other specific categories like DIV, CAP, or POS, and it is clearly marked as an RNS item, the most appropriate classification is the general regulatory filing category, RNS.
2017-04-11 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'The company news service from the London Stock Exchange' and 'In conformity with DTR 5.6.1R, the Company notifies the market of the following:'. The content details the 'Total Voting Rights' as of a specific date (31 March 2017), which is a mandatory disclosure under transparency rules. This type of general regulatory notification that doesn't fit a more specific category like Director's Dealing (DIRS) or Major Shareholding (MRQ) is best classified as a general Regulatory Filing (RNS). The document length is short (2190 chars), but the content is the filing itself, not an announcement *about* a filing.
2017-03-31 English
Licensing Agreement and Share Acquisition
M&A Activity Classification · 99% confidence The document is identified by the 'RNS Number' header and the concluding statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a significant corporate action: entering into an Intellectual Property Licensing Agreement and acquiring a minority stake in a parent company. This type of announcement, which is a material event disclosure disseminated via the Regulatory News Service (RNS), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR, ER), a management change (MANG), or a director's dealing (DIRS). Since it is a general regulatory announcement, RNS is the appropriate code.
2017-03-31 English
Additional Listing
Regulatory Filings Classification · 98% confidence The document is very short (2070 characters) and begins with an 'RNS Number', indicating it is a regulatory announcement from the London Stock Exchange's news service. The content explicitly states an 'application has been made... for a total of 80,000 ordinary shares... to be admitted to the Official List' under a block listing for share option schemes. This describes a specific corporate action related to share issuance/capital structure change, but the format is a brief regulatory notification rather than a detailed filing like a 10-K or IR. Since it involves the issuance of new shares, the most specific category is 'Share Issue/Capital Change' (SHA). However, given the context of it being a brief RNS announcement detailing the admission of shares, it could also fit 'Regulatory Filings' (RNS) as a general announcement. Comparing SHA and RNS: SHA is for the *event* (share issue), while RNS is for the *format* (regulatory news service announcement). Since the core subject is the admission of new shares, SHA is the most precise classification for the underlying event, even if delivered via RNS. I will classify it as SHA as it directly addresses the capital change described.
2017-03-23 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document explicitly states it is an 'RNS Number' notification and details a transaction involving an 'Executive Director' selling ordinary shares. The content is a 'Notification of Dealing Form' concerning a 'PDMR' (Person Discharging Managerial Responsibilities). This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The presence of the RNS header and the specific nature of the disclosure confirm the classification as DIRS, rather than the general RNS fallback.
2017-03-21 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.